BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23715747)

  • 1. Association between main Caspase gene polymorphisms and the susceptibility and prognosis of colorectal cancer.
    Wu Z; Li Y; Li S; Zhu L; Li G; Yu Z; Zhao X; Ge J; Cui B; Dong X; Tian S; Hu F; Zhao Y
    Med Oncol; 2013; 30(3):565. PubMed ID: 23715747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of caspase 8 and caspase 9 gene and colorectal cancer susceptibility and prognosis.
    Theodoropoulos GE; Gazouli M; Vaiopoulou A; Leandrou M; Nikouli S; Vassou E; Kouraklis G; Nikiteas N
    Int J Colorectal Dis; 2011 Sep; 26(9):1113-8. PubMed ID: 21538054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CASP8 -652 6N del polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
    Peng Q; Lao X; Tang W; Chen Z; Li R; Wang J; Deng Y; Li T; Qin X; Li S
    PLoS One; 2014; 9(2):e87925. PubMed ID: 24498403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspase 8 and caspase 9 gene polymorphisms and susceptibility to gastric cancer.
    Liamarkopoulos E; Gazouli M; Aravantinos G; Tzanakis N; Theodoropoulos G; Rizos S; Nikiteas N
    Gastric Cancer; 2011 Oct; 14(4):317-21. PubMed ID: 21461653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional polymorphisms in cell death pathway genes and risk of renal cell carcinoma.
    Zhu J; Qin C; Wang M; Yan F; Ju X; Meng X; Ding Q; Li P; Yang J; Cao Q; Zhang Z; Yin C
    Mol Carcinog; 2010 Sep; 49(9):810-7. PubMed ID: 20572163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The functional -94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer.
    Mohd Suzairi MS; Tan SC; Ahmad Aizat AA; Mohd Aminudin M; Siti Nurfatimah MS; Andee ZD; Ankathil R
    Cancer Epidemiol; 2013 Oct; 37(5):634-8. PubMed ID: 23806437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CASP8 -652 6N del polymorphism and cancer risk: a meta-analysis of 30 case-control studies in 50,112 subjects.
    Zhang F; Yang Y; Guo C; Wang Y
    Mutagenesis; 2012 Sep; 27(5):559-66. PubMed ID: 22513478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CASP8 -652 6N insertion/deletion promoter polymorphism is associated with renal cell carcinoma risk and metastasis.
    de Martino M; Haitel A; Schatzl G; Klingler HC; Klatte T
    J Urol; 2013 Aug; 190(2):717-22. PubMed ID: 23313206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calpain-10 SNP43 and SNP19 polymorphisms and colorectal cancer: a matched case-control study.
    Hu XQ; Yuan P; Luan RS; Li XL; Liu WH; Feng F; Yan J; Yang YF
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6673-80. PubMed ID: 24377587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma.
    Li C; Zhao H; Hu Z; Liu Z; Wang LE; Gershenwald JE; Prieto VG; Lee JE; Duvic M; Grimm EA; Wei Q
    Hum Mutat; 2008 Dec; 29(12):1443-51. PubMed ID: 18563783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CASP8 variants D302H and -652 6N ins/del do not influence the risk of colorectal cancer in the United Kingdom population.
    Pittman AM; Broderick P; Sullivan K; Fielding S; Webb E; Penegar S; Tomlinson I; Houlston RS
    Br J Cancer; 2008 Apr; 98(8):1434-6. PubMed ID: 18362937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The six-nucleotide deletion/insertion variant in the CASP8 promoter region is inversely associated with risk of squamous cell carcinoma of the head and neck.
    Li C; Lu J; Liu Z; Wang LE; Zhao H; El-Naggar AK; Sturgis EM; Wei Q
    Cancer Prev Res (Phila); 2010 Feb; 3(2):246-53. PubMed ID: 20086182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between survivin -31G>C polymorphism and susceptibility to sporadic colorectal cancer in a Southern Chinese population.
    Huang J; Wei Y; Zhou X; Wang L; Huang M; Wang J
    J Cancer Res Ther; 2019; 15(1):82-86. PubMed ID: 30880759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterozygous Ins/Del genotype of the CASP8 rs3834129 polymorphism significantly decreases the risk of coal workers' pneumoconiosis in a Chinese Han population: a case-control study.
    Hou ZF; Wang H; Ji SQ; Kang DM; Zhao H; Guo Y; Ma JF; Wang JZ; Ma X; Gao Y
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):7726-7733. PubMed ID: 34982434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APE1 polymorphisms are associated with colorectal cancer susceptibility in Chinese Hans.
    Zhang SH; Wang LA; Li Z; Peng Y; Cun YP; Dai N; Cheng Y; Xiao H; Xiong YL; Wang D
    World J Gastroenterol; 2014 Jul; 20(26):8700-8. PubMed ID: 25024628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation of ErbB4 confers risk of colorectal cancer in a Chinese Han population.
    Gao X; Zhang S; Zhu Z
    Cancer Biomark; 2014; 14(6):435-9. PubMed ID: 25335735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation between polymorphism in the promoter of DNA methyltransferase-3B and the risk of colorectal cancer].
    Bao Q; He BS; Chen LP; Gu L; Nie ZL; Wang SK
    Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Jan; 46(1):53-7. PubMed ID: 22490141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in genes of APE1, PARP1, and XRCC1: risk and prognosis of colorectal cancer in a northeast Chinese population.
    Li Y; Li S; Wu Z; Hu F; Zhu L; Zhao X; Cui B; Dong X; Tian S; Wang F; Zhao Y
    Med Oncol; 2013 Jun; 30(2):505. PubMed ID: 23430444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KRAS and VEGF gene 3'-UTR single nucleotide polymorphisms predicted susceptibility in colorectal cancer.
    Yang M; Xiao X; Xing X; Li X; Xia T; Long H
    PLoS One; 2017; 12(3):e0174140. PubMed ID: 28328959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of HLA-G 3'UTR polymorphisms and haplotypes with colorectal cancer susceptibility and prognosis.
    Dhouioui S; Laaribi AB; Boujelbene N; Jelassi R; Ben Salah H; Bellali H; Ouzari HI; Mezlini A; Zemni I; Chelbi H; Zidi I
    Hum Immunol; 2022 Jan; 83(1):39-46. PubMed ID: 34763955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.